Previous 10 | Next 10 |
The FDA signs off Molecular Templates' ([[MTEM]] +5.5%) Investigational New Drug application for MT-6402, ETB targeting PD-L1 that is enabled with MTEM’s antigen seeding technology, that allows a dual mechanisms of action that include the enzymatic destruction of ribosomes and the deli...
AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted bi...
Molecular Templates (MTEM) provides an update on the Phase 1 study for MT5111, a HER2 targeted engineered toxin bodies ((ETB)). To date, 16 study subjects have been treated in the dose escalation portion of this study. Five cohorts (0.5, 1.0, 2.0, 3.0, and 4.5 μg/kg/week) have bee...
Phase 1 Study Dose Escalation Ongoing in All HER2 Positive Tumor Types HER2 Positive Breast Cancer Expansion Cohort Planned to be Initiated in 1H21 Expansion Cohorts in Additional Tumors Types to Begin When MTD or Recommended Phase 2 Dose is Reached AUSTIN, Texas, Dec. 21, 2020 (GLO...
Molecular Templates is pioneering a new form of oncology therapy known as engineered toxin bodies - which use bacteria plus antibodies to target and kill cancer cells. The company has three candidates in trials and development partnerships agreed with Takeda and Vertex Pharmaceuticals...
AUSTIN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bo...
Gainers: Aurora Cannabis (ACB) +75%.Sundial Growers (SNDL) +57%.Modine Manufacturing (MOD) +41%.Akerna (KERN) +40%.Tilray (TLRY) +40%.Cooper-Standard (CPS) +35%.Mogo (MOGO) +32%.OrganiGram (OGI) +29%.Glu Mobile (GLUU) +28%.FTS International (FTSI) +21%.Losers: Assembly Bioscien...
Gainers: Aurora Cannabis (ACB) +82%, Sundial Growers (SNDL) +69%, Tilray (TLRY) +36%, OrganiGram Holdings Inc. (OGI) +30%, MEDNAX (MD) +19%.Losers: Assembly Biosciences (ASMB) -69%, Global Blood Therapeutics (GBT) -35%, AcelRx Pharmaceuti...
Molecular Templates (MTEM): Q3 GAAP EPS of -$0.47 beats by $0.08.Revenue of $4.3M (+18.8% Y/Y) misses by $1.5M.Press Release For further details see: Molecular Templates EPS beats by $0.08, misses on revenue
AUSTIN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” “MTEM” or “the Company”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted bi...
News, Short Squeeze, Breakout and More Instantly...
Molecular Templates Inc. Company Name:
MTEM Stock Symbol:
NASDAQ Market:
Molecular Templates Inc. Website:
AUSTIN, Texas, May 15, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary targeted biologic therapeutics, engineere...